NEUROMAGEN PHARMA
Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS. Neuromagen Pharma was founded in 2021 and was headquartered in Beer Sheva, Israel.
NEUROMAGEN PHARMA
Industry:
Biopharma Biotechnology Neuroscience
Founded:
2021-01-01
Address:
Be'er Sheva, HaDarom, Israel
Country:
Israel
Website Url:
http://www.neuromagen.com
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Global Site Tag
Current Employees Featured
Founder
Official Site Inspections
http://www.neuromagen.com
- Host name: do13.imark.co.il
- IP address: 161.35.72.86
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Neuromagen Pharma" on Search Engine
Neuromagen Pharma Ltd.
A new class of drugs. for neurodegenerative diseases. Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules which …See details»
Neuromagen Pharma - Crunchbase Company Profile & Funding
Founded Date 2021. Founders Gil Ben Menachem. Operating Status Active. Company Type For Profit. Contact Email [email protected]. Neuromagen Pharma develops …See details»
Neuromagen Pharma | LinkedIn
About us. Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate telomerase reverse transcriptase …See details»
Neuromagen Pharma Company Profile: Valuation, Funding
Contact Information. Website. www.neuromagen.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Primary Industry. Drug Discovery. …See details»
Neuromagen Pharma - Novel Drugs for Neurodegenerative …
Nov 24, 2023 Neuromagen Pharma Overview. Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules that …See details»
Neuromagen Pharma Announces the Approval of a NIS 1.8M …
2022 /PRNewswire/ -- Neuromagen Pharma Ltd., a company developing a new class of drugs for the treatment of degenerative and senescence-associated diseases, …See details»
Israeli drug that slowed Alzheimer’s, ALS in mice gets funding to …
Nov 2, 2021 They formed a company, Neuromagen Pharma, but did not have the funds to start the pre-clinical trials needed to prepare for human trials. Now, an Israeli funder has …See details»
Neuromagen Pharma Ltd. Receives FDA Orphan Drug …
May 5, 2022 Neuromagen Pharma Ltd. is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate telomerase reverse …See details»
Neuromagen Pharma Announces the Approval of a NIS 1.8M …
BEER-SHEVA, Israel, March 21, 2022 /PRNewswire/ -- Neuromagen Pharma Ltd., a company developing a new class of drugs for the treatment of degenerative and …See details»
Neuromagen Receives FDA Orphan Drug to Slow Progression of …
May 9, 2022 Israeli Neuromagen Pharma Ltd., a developer of drugs to treat degenerative and senescence-associated diseases, has received FDA Orphan Drug Designation for …See details»
Neuromagen Pharma Ltd. Receives FDA Orphan Drug …
05 May 2022 – Congratulations to Neuromagen Pharma Ltd. on their recent Orphan Drug Designation for AGS-499, its lead drug candidate. AGS-499 has shown significant …See details»
Neuromagen Pharma | VentureRadar
Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules which activate Telomerase Reverse Transcriptase (TERT) – an enzyme …See details»
Neuromagen Pharma to Present at the BIO-Europe Spring 2022 …
Neuromagen Pharma is an early-stage pharmaceutical company developing a new class of innovative small molecules which activate Telomerase – an enzyme which plays a …See details»
Potential ALS drug gets boost toward preclinical trials
November 3, 2021. A new class of small molecules for treating amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s Disease, and other neurodegenerative diseases, is …See details»
Neuromagen Pharma: Drug pipelines, Patents, Clinical trials
Explore Neuromagen Pharma with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Neuromagen Pharma | CipherBio
Biotech 2021. Neuromagen Pharma. edit_note Submit Changes. Be'er Sheva, Israel https://www.neuromagen.com/ Neuromagen Pharma develops drugs for …See details»
AGS 500 - AdisInsight - Springer
At a glance. Originator Ben Gurion University. Developer Neuromagen Pharma. Class Antihyperglycaemics; Skin disorder therapies; Small molecules. Mechanism of Action …See details»
Neuromagen Pharma - Crunchbase
Neuromagen Pharma develops drugs for neurodegenerative diseases including ALS.See details»
Neuromagen Pharma - Contacts, Employees, Board Members, …
Organization. Neuromagen Pharma. Connect to CRM. Save. Summary People Technology Signals & News Similar Companies. Highlights. Employee Profiles 1. About. …See details»
Neuromagen Pharma | VentureRadar
Biotech. Neuromagen Pharma is a pharmaceutical company developing a new class of innovative small molecules which activate Telomerase Reverse Transcriptase... ... Find …See details»